|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 05, 2018 ) The Global Bio Pharmaceuticals Market was worth $161.4 billion in 2016 and estimated to be growing at a CAGR of 9.2%, to reach $250.62 billion by 2021. Disease treatment techniques have been revolutionized with the use of bio pharmaceuticals or biologics on account of their efficiency against autoimmune diseases & cancer and better mode of action. The healthcare industry is expected to make a shift from traditional small molecule drugs to bio pharmaceuticals.
Bio Pharmaceuticals are drugs obtained from genetically modified sources through biotechnology methods such as hybridoma techniques, recombinant DNA techniques and purification process. These drugs are used in treatment of various diseases like cancer, metabolic, neurological, cardiovascular and other rare type of diseases. Bio pharmaceuticals have enhanced the quality of life of patients and improved the quality of healthcare.
Rising geriatric population which is prone to neurodegenerative and auto immune disorders provide a strong business base for the manufacturers. There is a huge demand for biopharmaceuticals due to increasing incidence of chronic diseases whose treatment is made possible with the use of these drugs. Side effects associated with the over consumption of drugs and high cost involved in manufacturing are few restraints for the market.
The global bio pharmaceuticals market is segmented on the basis of products into Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH). Monoclonal antibodies segment holds the highest number of shares in the product sector. Based on therapeutics, the market is bifurcated into Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and other therapeutic areas. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market.
Based on geography the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. North America is the largest market for bio pharmaceuticals. Technological advancement in the region is propelling the dominance of the region. Asia-Pacific is forecasted to develop as the fastest growing region for biopharmaceuticals market in the forecast period. Increasing awareness regarding biologic drugs is driving the market in the region.
View sample: https://www.marketdataforecast.com/market-reports/global-bio-pharmaceuticals-market-633/request-sample
Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc., and Novartis AG are some of the leading players in the market for biopharmaceuticals.
About MarketDataForecast™-
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
